Location History:
- Clarendon Hills, IL (US) (2004)
- Hiroshima, JP (2005)
Company Filing History:
Years Active: 2004-2005
Title: Innovations by Masahito Aoyama
Introduction
Masahito Aoyama is a notable inventor based in Hiroshima, Japan. He has made significant contributions to the field of medical imaging, particularly in the analysis of pulmonary nodules. With two patents to his name, Aoyama's work focuses on improving the accuracy of malignancy detection in lung nodules through advanced computerized methods.
Latest Patents
Aoyama's latest patents include a "Computerized method for determination of the likelihood of malignancy for pulmonary nodules on low-dose CT" and an "Automated computerized scheme for distinction between benign and malignant solitary pulmonary nodules on chest images." The first patent outlines a method that utilizes at least one computed tomography medical image to assess the malignancy of pulmonary nodules based on seven patient or image features. This innovative approach enhances diagnostic accuracy by employing a unique statistical analysis of these features. The second patent describes an automated method for analyzing nodules, which includes segmenting the nodule from a digital image and applying various classifiers to determine the likelihood of malignancy. This method can utilize both linear discriminant analyzers and artificial neural networks to improve diagnostic outcomes.
Career Highlights
Throughout his career, Aoyama has worked with reputable organizations such as Arch Development Corporation and the University of Chicago. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in medical imaging.
Collaborations
Some of Aoyama's notable coworkers include Kunio Doi and Qiang Li. Their collaborative efforts have further advanced the research and development of innovative diagnostic methods in the medical field.
Conclusion
Masahito Aoyama's contributions to the field of medical imaging through his patented inventions demonstrate his commitment to enhancing diagnostic accuracy for pulmonary nodules. His work continues to influence the medical community and improve patient outcomes.